FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Implant, Dermal, For Aesthetic Use

PMA: P090016 · Supplement: S038 · Decision Feb 7, 2020
Classifications
1
FEI Numbers
29
Registration Numbers
29

Basic Information

Device Name
Implant, Dermal, For Aesthetic Use
Trade Name
Belotero Balance Dermal Filler and Belotero Balance (+) Lidocaine Dermal Filler
PMA Number
P090016
Supplement Number
S038
Device Class
FDA Class 3
Product Code
LMH
Generic Name
Implant, dermal, for aesthetic use
Medical Specialty
Unknown
Advisory Committee
General, Plastic Surgery
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
February 7, 2020
Date Received
January 8, 2020
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

Changes to the NaHA assay for Belotero Balance Dermal Filler and Belotero Balance (+) Lidocaine Dermal Filler, including the introduction of 125 mL HDPE bottles, the use of two series of 40 samples from each series, and the use of an alternate water source for testing.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LMH Implant, Dermal, For Aesthetic Use